See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
The Oscars
Volodymyr Zelenskyy
Ukraine War
Social Media
Tariffs
US Politics
Basketball
Baseball
Donald Trump
Housing
Soccer
White House
Published • loading... • Updated

Specialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive Headwinds - Amphastar Pharma (NASDAQ:AMPH)

Summary by Benzinga
On Thursday, Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH) reported fourth-quarter adjusted EPS of 92 cents, up from 88 cents a year ago, but missing the consensus of 94 cents. Amphastar is a biopharmaceutical company focusing primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable, inhalation, and intranasal products. The company reported sales of $186.5 million, up 20% year over year, missing the consen…

2 Articles

All
Left
1
Center
1
Right
BenzingaBenzinga

Specialty Pharma Amphastar Stock Falls On Lower Than Expected Q4 Earnings, Analyst Sees Competitive Headwinds - Amphastar Pharma (NASDAQ:AMPH)

On Thursday, Amphastar Pharmaceuticals Inc. (NASDAQ:AMPH) reported fourth-quarter adjusted EPS of 92 cents, up from 88 cents a year ago, but missing the consensus of 94 cents. Amphastar is a biopharmaceutical company focusing primarily on developing, manufacturing, marketing, and selling generic and proprietary injectable, inhalation, and intranasal products. The company reported sales of $186.5 million, up 20% year over year, missing the consen…

·New York, United States
Read Full Article
The Motley FoolThe Motley Fool

Amphastar: Earnings Miss, Margins Drop @themotleyfool #stocks $AMPH

Amphastar Pharmaceuticals (NASDAQ:AMPH), a company involved in the development and commercialization of generic and proprietary pharmaceutical products, announced its financial results for the fourth quarter of 2024 on Feb. 27, 2025. The results revealed a slight miss in both earnings and revenue compared to analyst expectations. The company's adjusted earnings per share (EPS) came in at $0.92, underperforming the $0.94 anticipated by analysts, …

·Alexandria, United States
Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Motley Fool broke the news in Alexandria, United States on Friday, February 28, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Rancho Cucamonga

Rancho Cucamonga

You have read out of your 5 free daily articles.

Join us as a member to unlock exclusive access to diverse content.

News
For You
Search
BlindspotLocal